News - Namenda

Filter

Current filters:

Namenda

Popular Filters

Adamas Pharma earns $40 milestone in Forest deal

10-01-2014

California, USA-based Adamas Pharmaceuticals revealed yesterday (January 9) that it has received $40…

Adamas PharmaceuticalsdonepezilFinancialForest LaboratoriesMDX-8704NamendaNeurologicalPharmaceuticalResearch

Insights on the US Alzheimer's disease market

03-12-2012

The treatment of Alzheimer's disease (AD) offers a compelling commercial opportunity for the pharmaceutical…

AriceptEisaiExelonForest LaboratoriesGenericsMarkets & MarketingNamendaNeurologicalNorth AmericaNovartisPfizerPharmaceutical

Alzheimer's drug memantine fails to reduce significant agitation

03-05-2012

Memantine, a drug prescribed for Alzheimer's disease, does not ease clinically significant agitation…

EbixaMemantine HCLNamendaNeurologicalPharmaceuticalResearch

Forest Labs, Gedeon Richter plan 2012 filing for cariprazine

29-02-2012

Positive results from two phase III trials of Forest Laboratories and Gedeon Richter's new antipsychotic…

cariprazineForest LaboratoriesGedeon RichterHomeLexaproNamendaNeurologicalPharmaceutical

Back to top